All Posts

Pilar Ferrer, CEO of Amnova Biotech, was part of START SUMMIT representing the company in one of the Europe's leading startup conferences.

Behind this development is the support of CITES (Center for Technological, Business, and Social Innovation), the venture capital fund of the Sancor Seguros Group that specializes in deep tech and supports scientific startups with global potential from their earliest stages, providing capital, infrastructure, and a network of experts. Article published in 100 seguro, April 8, 2026. Read it in Spanish. Behind this development is the initiative of CITES (Center for Technological

Con resultados preclínicos prometedores, la iniciativa propone una alternativa innovadora frente a terapias que no logran revertir las lesiones en el corazón tras un infarto. Artículo publicado en La Voz - 23 de abril de 2026

The Argentine startup is developing a cell-free bioactive platform inspired by human birth tissue, with preclinical results in animal models showing improvements at 28 days, while CITES, the *deeptech* fund of the Sancor Seguros Group, is supporting the company with capital and R&D infrastructure. Article published in Mercado - April 10, 2026